Morgan Stanley’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $941K | Buy |
150,288
+50,841
| +51% | +$318K | ﹤0.01% | 5126 |
|
|
2025
Q1 | $583K | Sell |
99,447
-63,582
| -39% | -$373K | ﹤0.01% | 5263 |
|
|
2024
Q4 | $1.34M | Sell |
163,029
-20,965
| -11% | -$172K | ﹤0.01% | 4935 |
|
|
2024
Q3 | $1.64M | Buy |
183,994
+101,154
| +122% | +$901K | ﹤0.01% | 4765 |
|
|
2024
Q2 | $626K | Sell |
82,840
-4,016
| -5% | -$30.4K | ﹤0.01% | 5187 |
|
|
2024
Q1 | $682K | Sell |
86,856
-78,678
| -48% | -$618K | ﹤0.01% | 5169 |
|
|
2023
Q4 | $1.47M | Buy |
165,534
+144,450
| +685% | +$1.28M | ﹤0.01% | 5113 |
|
|
2023
Q3 | $189K | Sell |
21,084
-59,581
| -74% | -$534K | ﹤0.01% | 5602 |
|
|
2023
Q2 | $996K | Buy |
80,665
+8,072
| +11% | +$99.7K | ﹤0.01% | 4833 |
|
|
2023
Q1 | $674K | Buy |
72,593
+7,990
| +12% | +$74.1K | ﹤0.01% | 5084 |
|
|
2022
Q4 | $678K | Buy |
64,603
+9,451
| +17% | +$99.2K | ﹤0.01% | 5073 |
|
|
2022
Q3 | $1M | Buy |
55,152
+613
| +1% | +$11.1K | ﹤0.01% | 4878 |
|
|
2022
Q2 | $772K | Buy |
54,539
+53,430
| +4,818% | +$756K | ﹤0.01% | 5183 |
|
|
2022
Q1 | $24K | Buy |
1,109
+575
| +108% | +$12.4K | ﹤0.01% | 7064 |
|
|
2021
Q4 | $9K | Buy |
+534
| New | +$9K | ﹤0.01% | 7491 |
|